|Pantaleo: Poxvirus-Based Vaccine Development
|Combo: DNA, protein & vector vaccines
|Study Start Date:
|Study Made Public:
Evaluation on non-human primates of safety and immunogenicity for priming with NYVAC or DNA +/-gp120, followed by protein boosts in combination with either NYVAC or DNA
CAVD 371 (AUP 512) is a non-human primate study comparing DNA/protein and NYVAC/protein prime/boost regimens.
Sign in to see full information about this study and to download study data.